Bobby Wiseman, 51, was diagnosed as an infant with hemophilia, the rare genetic disease that prevents blood from clotting. He tested positive for HIV and hepatitis C when he was 11 after catching the viruses from contaminated blood-clotting products. As a teenager, he spent 45 days hospitalized in a coma from massive gastrointestinal bleeding. In 2018, he became the first patient in a study to receive an experimental gene therapy for his form of the bleeding disorder.Read Long Article
